Page last updated: 2024-10-28

idebenone and MS (Multiple Sclerosis)

idebenone has been researched along with MS (Multiple Sclerosis) in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Idebenone was well tolerated but did not inhibit disability progression or CNS tissue destruction."2.94Idebenone does not inhibit disability progression in primary progressive MS. ( Bielekova, B; Komori, M; Kosa, P; Leinonen, M; Masvekar, R; Phillips, J; Sandford, M; Wichman, A; Wu, T, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kosa, P1
Wu, T1
Phillips, J1
Leinonen, M1
Masvekar, R1
Komori, M1
Wichman, A1
Sandford, M1
Bielekova, B1
Chang, M1
Szewka, AJ1
Toffoli, D1
Newman, NJ1
Biousse, V1

Trials

1 trial available for idebenone and MS (Multiple Sclerosis)

ArticleYear
Idebenone does not inhibit disability progression in primary progressive MS.
    Multiple sclerosis and related disorders, 2020, Volume: 45

    Topics: Axons; Biomarkers; Disease Progression; Double-Blind Method; Humans; Multiple Sclerosis; Multiple Sc

2020

Other Studies

2 other studies available for idebenone and MS (Multiple Sclerosis)

ArticleYear
Leber's hereditary optic neuropathy misdiagnosed as optic neuritis and Lyme disease in a patient with multiple sclerosis.
    BMJ case reports, 2018, Dec-07, Volume: 11, Issue:1

    Topics: Adult; Antioxidants; Diagnosis, Differential; Diagnostic Errors; Humans; Lyme Disease; Magnetic Reso

2018
Updates in neuro-ophthalmology. Highlights from the 37th annual meeting of the North American Neuro-Ophthalmology Society,February 5-10, 2011, Vancouver, Canada.
    Reviews in neurological diseases, 2011, Volume: 8, Issue:1-2

    Topics: Burkholderia; Canada; Giant Cell Arteritis; Humans; Multiple Sclerosis; Neurology; Ophthalmology; Op

2011